Press release
Peptide Antibiotics: A Leading Driver Behind Rising Prevalence Of Infectious Diseases Fuels Peptide Antibiotics Market Market Expansion in 2025
Peptide Antibiotics Market
What Will the Peptide Antibiotics Industry Market Size Be by 2025?
The market size of peptide antibiotics has seen a substantial increase in recent years. It's predicted to expand from $5.25 billion in 2024 to $5.77 billion in 2025 with a compound annual growth rate (CAGR) of 9.8%. The historic growth can be accredited to several factors such as the discovery and promotion of peptide antibiotics, a higher resistance to antibiotics, a surge in the occurrence of infectious diseases, advancement in peptide synthesis technologies, and the expansion of the pharmaceutical industry.
What's the Long-Term Growth Forecast for the Peptide Antibiotics Market Size Through 2029?
The market size of peptide antibiotics is anticipated to experience significant growth in the coming years, reaching "$8.29 billion in 2029 with a compound annual growth rate (CAGR) of 9.5%. Factors contributing to this growth in the predicted period include a focus on the development of innovative antibiotics, a rise in global antibiotic-resistant infections, an increase in research and development activities related to antimicrobial peptides, and regulatory encouragement for new antibiotic sanctions. The forecast period will also observe major trends such as examining natural resources for antimicrobial peptides, the application of peptide antibiotics in animal healthcare, focus on peptide engineering to enhance effectiveness, development of mixed peptide antibiotics, and implementation of artificial intelligence and machine learning in the discovery of peptide antibiotics.
View the full report here:
https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report
What Are the Key Growth Drivers Fueling the Peptide Antibiotics Market Expansion?
The upsurge in various infectious diseases prevalence is anticipated to boost the peptide antibiotics market's growth. Infectious diseases, sourced by detrimental microorganisms such as bacteria, fungi, parasites, among others, are on the rise due to rapid urbanization, climate change, an increasing risk of disease emergence and alike. These conditions have surged the demand for peptide antibiotics, which function by rupturing physical cell membranes, thereby enhancing antibacterial activity. A case in point - the World Health Organization, an intergovernmental organization based in Switzerland, reported an over seven million surge in dengue cases in America region by April 2024, which substantially exceeded 4.6 million total cases in 2023. Hence, the heightened incidence of infectious diseases substantiates the growth of the peptide antibiotics market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7780&type=smp
Which Emerging Trends Are Transforming the Peptide Antibiotics Market in 2025?
A rising trend in the peptide antibiotics market is the formation of strategic alliances, with major industry players increasingly engaging in such partnerships to advance their market presence and mutually benefit from shared resources. This trend was exemplified in January 2022 when US digital cell biology firm Berkeley Lights teamed up with Aanika Biosciences. This collaboration will allow Aanika to utilize Berkeley Lights' rapid and high-capacity functional screening service for precise detection and enhancement of antimicrobial peptides (AMPs); these specific peptides can eradicate harmful bacteria, especially those causing foodborne diseases. Additionally, the Beacon Optofluidic Platform will aid in recognizing bacteria-damaging peptides to create an innovative antibacterial tag. This tag will be incorporated into their bacterial spore-based barcoding technology, thus ensuring food supply chain safety. Aanika Biosciences is a biotech firm based in the USA.
How Is the Peptide Antibiotics Market Segmented?
The peptide antibiotics market covered in this report is segmented -
1) By Type: Ribosomal Synthesized Peptide Antibiotics, Non-Ribosomal Synthesized Peptide Antibiotics
2) By Drugs: Daptomycin, Dalbavancin, Telavancin, Other Drugs
3) By Disease Outlook: Skin Infection, HABP Or VABP, Blood Stream Infection, Other Diseases
4) By Distribution Channel: Hospitals, Homecare, Specialty Clinics, Other Distribution Channels
Subsegments:
1) By Ribosomal Synthesized Peptide Antibiotics: Aminoglycosides, Macrolides, Tetracyclines, Lincosamides
2) By Non-Ribosomal Synthesized Peptide Antibiotics: Bacitracins, Vancomycin, Polymyxins, Cyclic Lipopeptides
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7780&type=smp
Which Companies Are Leading the Charge in Peptide Antibiotics Market Innovation?
Major companies operating in the peptide antibiotics market include Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sandoz International GmbH, Xellia APS, Johnson & Johnson Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Lupin Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Wockhardt Ltd., Zydus Lifesciences Limited, Alkem Laboratories Limited, Allecra Therapeutics GmbH, Antabio, Basilea Pharmaceutica Ltd., BioVersys AG
Which Regions Are Leading the Global Peptide Antibiotics Market in Revenue?
North America was the largest region in the peptide antibiotics market in 2024. The regions covered in the peptide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7780
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Antibiotics: A Leading Driver Behind Rising Prevalence Of Infectious Diseases Fuels Peptide Antibiotics Market Market Expansion in 2025 here
News-ID: 4180294 • Views: …
More Releases from The Business Research Company
Leading Companies Spearheading Innovation and Growth in the Automotive X-By-Wire …
The automotive industry is undergoing a major transformation driven by innovative technologies that replace traditional mechanical linkages with electronic controls. Among these advancements, automotive x-by-wire systems are gaining significant attention for their potential to improve vehicle performance, safety, and efficiency. Let's explore the market size, key players, dominant trends, and segmentation within this rapidly evolving sector.
Projected Market Size and Growth of the Automotive X-By-Wire Systems Market
The automotive x-by-wire…
Automotive Vehicle to Everything (V2X) Communications Market Overview: Major Seg …
The automotive vehicle-to-everything (V2X) communications market is positioned for rapid expansion over the coming years as advanced technologies reshape transportation. With innovations in connectivity and safety playing critical roles, the market is set to evolve significantly, impacting how vehicles interact with each other and their surroundings. Below is an overview of the market's growth prospects, leading companies, emerging trends, and key segments shaping this dynamic industry.
Forecast for Growth in the…
Key Players and Competitive Environment in the Automotive Windshield Market
The automotive windshield market is on track for significant expansion in the coming years, driven by technological advancements and evolving vehicle designs. With the rise of electric and autonomous vehicles, alongside innovations in safety and display integration, this sector is set to see remarkable growth. Let's explore the market size forecasts, key players, emerging trends, and the segmentation that shapes this dynamic industry.
Forecasted Growth and Market Size of the Automotive…
Leading Companies Solidify Their Presence in the Autonomous Boats Market
The autonomous boats sector is gaining significant traction as technological advancements and industry demands evolve. With increasing interest in unmanned operations and sustainable marine solutions, this market is set for notable expansion over the coming years. Let's explore the current market size, key players, emerging trends, and segmentation to understand the direction this innovative industry is heading.
Projected Growth and Market Size of Autonomous Boats
The autonomous boats market is…
More Releases for Peptide
ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support.
ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
